Albendazole Side Effects
Medically reviewed by Drugs.com. Last updated on Aug 2, 2024.
Applies to albendazole: oral tablet.
Common side effects of albendazole
Some side effects of albendazole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- stomach pain
Less common side effects
- nausea
Rare side effects
- dizziness
- thinning or loss of the hair
Incidence not known
- lack or loss of strength
Serious side effects of albendazole
Along with its needed effects, albendazole may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking albendazole:
Less common side effects
- fever
Rare side effects
- black, tarry stools
- bleeding gums
- blood in the urine or stools
- chest pain
- chills
- cough
- painful or difficult urination
- pinpoint red spots on the skin
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
- unusual bleeding or bruising
- unusual tiredness or weakness
Incidence not known
- blistering, peeling, or loosening of the skin
- blurred vision
- dark urine
- diarrhea
- general feeling of tiredness or weakness
- headache
- itching
- joint or muscle pain
- light-colored stools
- red, irritated eyes
- seizures
- stomach pain, continuing
- tightness in the chest
- vomiting
- yellow eyes or skin
For healthcare professionals
Applies to albendazole: compounding powder, oral tablet, oral tablet chewable.
General adverse events
Side effects differed between hydatid disease and neurocysticercosis. Symptoms were generally mild and resolved without treatment. Therapy was discontinued primarily due to leukopenia (0.7%) or hepatic abnormalities (3.8% in hydatid disease).[Ref]
Hepatic
- Very common (10% or more): Elevated liver enzymes (up to 16%)
- Uncommon (0.1% to 1%): Hepatitis
- Frequency not reported: Hepatotoxicity, hepatic abnormalities, jaundice, hepatocellular damage
- Postmarketing reports: Acute liver failure[Ref]
Mild to moderate elevated liver enzymes were very common.
Severe hepatic abnormalities, including jaundice and hepatocellular damage (possibly irreversible), have been reported during prolonged higher dose treatment of hydatid disease.
Elevated liver enzymes and hepatitis have also been reported during postmarketing experience.[Ref]
Nervous system
- Very common (10% or more): Headache (up to 11%)
- Common (1% to 10%): Raised intracranial pressure, dizziness, neurological events
- Uncommon (0.1% to 1%): Vertigo, meningeal signs
- Postmarketing reports: Somnolence, convulsion[Ref]
Headache has also been reported during postmarketing experience.[Ref]
Gastrointestinal
- Common (1% to 10%): Epigastric/abdominal pain, nausea, vomiting, upper gastrointestinal (GI) symptoms, GI disturbances
- Uncommon (0.1% to 1%): Diarrhea
- Rare (less than 0.1%): Pancreatitis[Ref]
Upper GI symptoms (e.g., epigastric/abdominal pain, nausea, vomiting) and GI disturbances (abdominal pain, nausea, vomiting) were reported.
Diarrhea has also been reported during postmarketing experience.[Ref]
Dermatologic
- Common (1% to 10%): Reversible alopecia (thinning of hair, moderate hair loss)
- Uncommon (0.1% to 1%): Itchiness, skin rashes
- Postmarketing reports: Erythema multiforme, Stevens-Johnson syndrome[Ref]
Reversible alopecia (thinning of hair and moderate hair loss) has also been reported during postmarketing experience.[Ref]
Other
- Common (1% to 10%): Fever, hyperpyrexia
- Postmarketing reports: Asthenia[Ref]
Fever has also been reported during postmarketing experience.[Ref]
Hematologic
- Common (1% to 10%): Leukopenia
- Rare (less than 0.1%): Low red cell count, pancytopenia, thrombocytopenia
- Frequency not reported: Granulocytopenia, agranulocytosis
- Postmarketing reports: Aplastic anemia, bone marrow suppression, neutropenia[Ref]
Agranulocytosis and pancytopenia have also been reported during postmarketing experience.
Patients with liver disease (including hepatic echinococcosis) appeared more susceptible to bone marrow suppression.[Ref]
Hypersensitivity
Ocular
- Rare (less than 0.1%): Ocular maculopathy
- Frequency not reported: Retinal damage
- Postmarketing reports: Blurred vision[Ref]
Musculoskeletal
- Rare (less than 0.1%): Bone pain
- Postmarketing reports: Rhabdomyolysis[Ref]
Genitourinary
- Rare (less than 0.1%): Proteinuria
Renal
- Postmarketing reports: Acute renal failure[Ref]
References
1. (2001) "Product Information. Albenza (albendazole)." SmithKline Beecham
2. Cerner Multum, Inc. "Australian Product Information."
Frequently asked questions
More about albendazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Dosage information
- During pregnancy
- Drug class: anthelmintics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Albendazole side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.